Gross Profit On Sales változás Dátum
AbbVie USD 9.56B 95M 2023-09
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Agios Pharmaceuticals USD 6.52M 249K 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amgen USD 5.08B 14M 2023-12
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Dynavax Technologies USD 46.91M 9.38M 2023-12
Exelixis USD 453.15M 1M 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Incyte USD 949.29M 84.66M 2023-12
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Repligen USD 67.61M 8.34M 2023-12
Rigel Pharmaceuticals USD 26.87M 1.06M 2023-09
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Teva Pharmaceutical Industries USD 1.9B 20M 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Neurocrine Biosciences Bruttó Nyereség Az Eladási - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Mar 2024.